Public health. Rethinking influenza

Science. 2009 Oct 2;326(5949):50. doi: 10.1126/science.1179475.
No abstract available

MeSH terms

  • Adjuvants, Immunologic
  • Animals
  • Antiviral Agents / therapeutic use
  • Developed Countries
  • Developing Countries
  • Disease Outbreaks* / prevention & control
  • Humans
  • Influenza A Virus, H1N1 Subtype* / immunology
  • Influenza Vaccines* / adverse effects
  • Influenza Vaccines* / immunology
  • Influenza, Human* / epidemiology
  • Influenza, Human* / prevention & control
  • Influenza, Human* / virology
  • Mass Vaccination
  • Orthomyxoviridae* / immunology
  • Population Surveillance

Substances

  • Adjuvants, Immunologic
  • Antiviral Agents
  • Influenza Vaccines